Immune dysfunction in the elderly: effect of thymic hormone administration on several in vivo and in vitro immune function parameters. 1990

U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
Institute of Internal Medicine, University of Padova, Italy.

The effects of short-term thymic hormone administration on age-associated immune function were evaluated. Two groups of individuals greater than 65 years of age were treated for 30 days with thymic extracts (TP1) or placebo; before and after this treatment a panel of in vitro and in vivo parameters was determined according to a very rigorous experimental protocol. In most individuals, TP1 treatment was associated with an improvement in cutaneous delayed-type response to PPD. Moreover, an increase in a circulating T cell subpopulation bearing the CD45R surface antigen ("virgin" T cells), and in NK cell cytotoxic activity was also observed in some subjects. Finally, lymphocyte responsiveness to PHA tended to increase, while no effect on lymphocyte ability to produce IL-2 following mitogen stimulation was observed. These findings suggest that TP1 treatment may influence age-related alterations in immune function parameters in some subjects.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007107 Immune System The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. Immune Systems,System, Immune,Systems, Immune
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005260 Female Females

Related Publications

U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
May 1991, Mechanisms of ageing and development,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
February 1990, Journal of endocrinological investigation,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
August 2019, Molecular immunology,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
July 1994, European journal of endocrinology,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
January 1976, Nutrition and metabolism,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
November 1973, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
January 1994, Thymus,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
February 1977, Biochemical pharmacology,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
June 2008, FEMS immunology and medical microbiology,
U Fagiolo, and A Amadori, and F Borghesan, and R Zamarchi, and M L Veronese, and G De Silvestro, and E Passarella, and G Crepaldi
February 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!